NVIV
InVivo Therapeutics Holdings Corp
NVIV
NVIV
Delisted
NVIV was delisted on the 12th of February, 2024.
38 hedge funds and large institutions have $39.5M invested in InVivo Therapeutics Holdings Corp in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less capital invested
Capital invested by funds: $43.9M → $39.5M (-$4.44M)
Holders
38
Holding in Top 10
1
Calls
$3.91M
Puts
$2.36M
Top Buyers
| 1 | +$947K | |
| 2 | +$682K | |
| 3 | +$445K | |
| 4 |
Goldman Sachs
New York
|
+$410K |
| 5 |
EIM
Emerson Investment Management
Boston,
Massachusetts
|
+$267K |
Top Sellers
| 1 | -$536K | |
| 2 | -$327K | |
| 3 | -$251K | |
| 4 |
Millennium Management
New York
|
-$173K |
| 5 |
Bank of New York Mellon
New York
|
-$148K |